SCM
UROV

Sio Capital Management’s Urovant Sciences Ltd. UROV Stock Holding History

Sio Capital Management’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-160,442
Closed -$2.49M – 100
2019
Q4 		$2.49M Sell
160,442
-28,400
-15% -$308K 0.59% 40
2019
Q3 		$1.79M Sell
188,842
-31,200
-14% -$271K 0.58% 46
2019
Q2 		$1.74M Buy
220,042
+5,000
+2% +$41K 0.42% 51
2019
Q1 		$2.16M Sell
215,042
-592,818
-73% -$6.08M 0.58% 53
2018
Q4 		$5.32M Buy
807,860
+216,406
+37% +$1.97M 1.94% 15
2018
Q3 		$7.1M Buy
+591,454
New +$6.99M 2.44% 12

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Sio Capital Management's UROV Position: Q1 2020 in Review

Sio Capital Management sold out of Urovant Sciences Ltd. (UROV) in Q1 2020, closing a stake of 160,442 shares — an estimated $2.49M sold.

Sio Capital Management first reported a position in UROV in Q3 2018 and held it in 6 quarters. The position peaked at $7.1M in Q3 2018. 24 funds tracked by Wall St. Rank hold UROV as of Q1 2020.

  • Sio Capital Management reported no remaining Urovant Sciences Ltd. position as of Q1 2020 after selling out during the quarter.
  • Sio Capital Management sold 160,442 Urovant Sciences Ltd. shares in Q1 2020, an estimated $2.49M.
  • Sio Capital Management first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 6 quarters.
  • Sio Capital Management's Urovant Sciences Ltd. position peaked at $7.1M in Q3 2018.
  • 24 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2020.

Based on Sio Capital Management's 13F filing for Q1 2020, filed 15 May 2020.